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Correspondence / European Journal of Vascular and Endovascular Surgery 43 (2012) 610–613612a positive effect on outcome in patients following revascularisation.
But we cannot comment on this on the basis of our data. Further-
more, to our knowledge cilostazol is approved only for claudicants,
not however for patients with CLI, in Europe. Therefore, we believe
our data reﬂect the local situation.
The three patients with extra-anatomic reconstructions were
considered too frail for aortic surgery and therefore received extra-
anatomic revascularisations as primary operation. None oft the
patients had undergone previous vascular surgery, as we described
initial treatment inpatients presentingwith theirﬁrst episode of CLI.M. Engelhardt*
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doi:10.1016/j.ejvs.2012.02.004Response to Letter to the Editor Re “What are the Risk Factors
for Renal Failure Following Open Elective Abdominal Aortic
Aneurysm Repair?”
We would like to thank the authors of the letter for their
comments regarding ourmanuscript.1 We agree that intraoperative
blood loss and subsequent transfusion are likely to be important
risk factors for the development of post-operative renal failure
following major surgery of all types. The aim of this study was
however to identify the pre-operative risk factors associated with
post-operative renal failure following open elective abdominal
aortic aneurysm (AAA) repair. The ability to identify high-risk
patients pre-operatviely is important as renal optimisation strate-
gies, including the avoidance of nephrotoxic agents in the peri-
operative period and the use of autotransfusion, can be decided
on prior to surgery. At our centre autotransfusion use is routine
for open elective AAA repair. It is also being used increasingly
throughout the North West of England with cell salvage utilised
for 30% of open elective AAA repairs between 2000 and 2005 and
for 47% of cases between 2006 and 2010 (OR 2.07, 95%CI 1.75–
2.46, p < 0.001, c2).
We agree with Gokalp and colleagues that it is also important
to identify the modiﬁable peri-operative risk factors that are asso-
ciated with the development of post-operative renal failure. One
of the most signiﬁcant peri-operative risk factors for renal failure
on univariate analysis in our cohort is the return to theatre for
bleeding with renal failure occurring in 21.3% of patients
requiring re-operation compared to 4.9% of patients who did
not require re-operation (OR 5.27, 95%CI 3.43–8.11, p < 0.001,
c2). Further analyses of the peri-operative risk factors that are
associated with the development of post-operative renal failure
are planned.I of original article: 10.1016/j.ejvs.2012.02.021. DOI of original article: 10.1016/j.ejvs.2012.02.019.DOReference
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We congulatulate the authors for the study about the predispos-
ing rick factors of renal disfunction following elective abdominal
aortic aneurysm repair.1 We believe that the effect of perioperative
blood transfusion onpostoperative renal failure should be evaluated
in this large study group as well, regarding many papers suggesting
this result for either cardiac or noncardiac surgery.2–4 If the relation
between blood transfusion and postoperative renal failure can be
shown especially for major abdominal vascular surgery, methods
like autotransfusion should be considered carefully and at length.References
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Figure 1. Kaplan–Meier survival analysis according to type of carotid intervention. CAS
– Carotid artery stenting; CEA – Carotid endarterectomy.
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doi:10.1016/j.ejvs.2012.02.021Muscle Over Mind?In his recent EJVES publication, Prof. Ross Naylor has provided
yet another strong message regarding the unconvincing argumen-
tation favoring CAS on basis of cardiac outcome.1 Internal audit of
our institution’s prospective vascular surgery database regarding
outcome after carotid intervention (98% symptomatic) has shown
a non-signiﬁcant increase in perioperative Troponin-T release for
CEA: 11/199(5.5%) vs. 3/101(3.0%), p ¼ 0.32. Over follow-up of
3.7  1.9 years no difference was observed in survival (Fig. 1). Using
propensity-adjusted Cox-regression analysis, the hazard ratio for
death after CEA was 1.05, 95%CI:0.6–1.8 (p ¼ 0.86). Consequently,
we cannot recommend CAS on the basis of life expectancy
following perioperative cardiac ischemia.
Inversely, data from ICSS sub-studies show a three-fold increase
in risk of new silent ischemic brain lesions for patients undergoing
CAS, which is associated with deterioration in cognitive function 6
months after treatment.2,3 Such deterioration was not observed
after CEA. The signiﬁcance of these new brain injuries for long-
term survival and quality of life is still unclear, as asymptomatic
cerebral embolization and cognitive function were never consid-
ered as study endpoints in major RCTs.
In conclusion, the marginal beneﬁt in periprocedural heart
ischemia favoring CAS (not observed in ICSS) may be signiﬁcantly
offset by the more frequent occurrence of overt and occult
cerebral embolization. Since these new brain lesions reportedly
inﬂuence cognitive function, shouldn’t patients be made aware of
this when informed consent is given? In the prospect of equivalent
survival expectancy, can doctors decide for muscle over mind?DOI of original article: 10.1016/j.ejvs.2011.10.016.Conﬂict of Interest
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